Non-selective beta-blockers enhance resolution of induced infections in animals and healthcare-associated infections in humans

Healthcare-associated infections (HAIs) pose significant risks, leading to increased morbidity, mortality, and costs, exacerbated by multi-drug-resistant microorganisms. This study aimed to evaluate pharmacological prophylaxis targeting sympathetic reflex control of immunity to mitigate systemic infections, offering a novel approach to combating HAIs. The study included animal experiments and a retrospective analysis of orthopedic surgery patients in Romagna, Italy. Young female pigs were intravenously inoculated with Escherichia coli (E. coli) and divided into two groups: propranolol-treated (non-selective β-blocker; 3 mg/kg; 3x/day orally) and vehicle-treated, starting two days before infection. Parameters such as bacteraemia, serum cytokines, biochemical profile, blood count, lactate, glycemia, and flow cytometry were assessed. Additionally, a retrospective analysis of 92,649 orthopedic surgery hospitalizations (2017-2022) examined the association of non-selective and selective β1-blockers with HAI development using conditional logistic regression. Propranolol-treated pigs exhibited a disinhibited immune response to systemic infection, clearing circulating bacteria much earlier than vehicle-treated animals. The retrospective analysis showed that patients on non-selective beta-blockers had a 71.7% reduced risk of developing HAIs, while those on selective β1-blockers had an 18% higher risk. These findings suggest that targeting sympathetic reflex control of immunity via pharmacological prophylaxis may reduce HAIs in surgical patients.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-11-05
DOI
https://doi.org/10.1038/s41598-025-22723-7
Primary Topic
Surgical site infection prevention
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Non-selective beta-blockers enhance resolution of induced infections in animals and healthcare-associated infections in humans

Augusta Zannoni, Tiziana Lazzarotto, Davide Martelli, Paola Rucci et al.
Scientific Reports
Surgical site infection prevention
article

Non-selective beta-blockers enhance resolution of induced infections in animals and healthcare-associated infections in humans

Augusta Zannoni, Tiziana Lazzarotto, Davide Martelli, Paola Rucci, Marco Luppi, Yugeesh R. Lankadeva, Clive Newton May, Roberto Amici, Stefano Ratti, Alberto Elmi, Robin M. McAllen, Matteo Cerri, Domenico Ventrella, Alessandra Occhinegro, Luca Alberti, Maddalena Giannella, Alessandra Cappellini, Timna Hitrec, Davide Golinelli, Maria Laura Bacci, Domenico Tupone, Patrícia Passaglia, Simona Rosa, Silvia Felici, Emiliana Piscitiello, Ludovico Taddei, Michael J. McKinley, Pierluigi Viale
article en

Abstract

Healthcare-associated infections (HAIs) pose significant risks, leading to increased morbidity, mortality, and costs, exacerbated by multi-drug-resistant microorganisms. This study aimed to evaluate pharmacological prophylaxis targeting sympathetic reflex control of immunity to mitigate systemic infections, offering a novel approach to combating HAIs. The study included animal experiments and a retrospective analysis of orthopedic surgery patients in Romagna, Italy. Young female pigs were intravenously inoculated with Escherichia coli (E. coli) and divided into two groups: propranolol-treated (non-selective β-blocker; 3 mg/kg; 3x/day orally) and vehicle-treated, starting two days before infection. Parameters such as bacteraemia, serum cytokines, biochemical profile, blood count, lactate, glycemia, and flow cytometry were assessed. Additionally, a retrospective analysis of 92,649 orthopedic surgery hospitalizations (2017-2022) examined the association of non-selective and selective β1-blockers with HAI development using conditional logistic regression. Propranolol-treated pigs exhibited a disinhibited immune response to systemic infection, clearing circulating bacteria much earlier than vehicle-treated animals. The retrospective analysis showed that patients on non-selective beta-blockers had a 71.7% reduced risk of developing HAIs, while those on selective β1-blockers had an 18% higher risk. These findings suggest that targeting sympathetic reflex control of immunity via pharmacological prophylaxis may reduce HAIs in surgical patients.

Scientific ReportsVol. 15(1)
University of Pisa (IT), Oregon Health & Science University (US), The University of Melbourne (AU), Universidade de São Paulo (BR), Florey Institute of Neuroscience and Mental Health (AU), Azienda Unità Sanitaria Locale Della Romagna (IT), Azienda USL di Bologna (IT), Neurological Surgery (US), University of Bologna (IT)
National Health and Medical Research Council
Openalex Percentile: Top 49%
Surgical site infection prevention
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.